Amanda Regio Pereira

Amanda Regio Pereira

Auto-generated profile, based on publicly available information

Amanda Regio Pereira

Sydney Melanoma Diagnostic Centre Royal Prince Alfred Hospital Camperdown Australia

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2010 in NeuroImage
Verified
Journal Article
Closed access
UCUniversity lin Campinas
University lin Campinas
CVClarissa Valise
Clarissa Valise
ASAndré Vital Saúde
André Vital Saúde
APAmanda Régio Pereira
Amanda Régio Pereira
FPFabricio Pereira
Fabricio Pereira
FCFernando Cendes
Fernando Cendes

9 October 2018 in Australasian Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
PGPascale Guitera
Pascale Guitera
HCHelena Collgros
Helena Collgros
CMChristine M Madronio
Christine M Madronio
CGChristopher Goumas
Christopher Goumas
GMGraham J Mann
Graham J Mann
ACAnne Cust
Anne Cust

30 March 2010 in Neurology
Verified
Journal Article
Closed access
PDF file
UCUniversity lin Campinas
University lin Campinas
MMM.E. Morita
M.E. Morita
AAA. Alessio
A. Alessio
APA.R. Pereira
A.R. Pereira
MBM.L.F. Balthazar
M.L.F. Balthazar
FCFernando Cendes
Fernando Cendes
Objective: To investigate clinical, neuropsychological, and MRI abnormalities (gray matter atrophy [GMA] and white matter atrophy [WMA]) in surgical mesial temporal lobe epilepsy (MTLE) patients with and without familial antecedent for epilepsy. Methods: A cohort study including 69 operated patients with unilateral MTLE, divided into a group of 29 patients (mean age 35.8 ± 10.4 years) with a negative family history (FH) of epilepsy and a group of 40 patients (32.8 ± 10 years) with a positive FH. We performed voxel-based morphometry (VBM) on preoperative MRIs and investigated possible clinical and neuropsychological differences between the 2 groups. We also performed VBM and t tests to compare the patients9 groups with normal controls. Results: The negative-FH group had lower IQ scores (p = 0.004), performed poorer on the Boston Naming Test (p = 0.02) and on delayed recall (p = 0.03), and presented a more prominent asymmetry index of hippocampal volume (p = 0.04) and more frequent initial precipitating injuries (p = 0.023). VBM showed a more restricted pattern of GMA in the positive-FH group and a more bilateral and widespread pattern of GMA in the negative-FH group, involving thalami, temporal, frontal, parietal, and occipital lobes. WMA was widespread and bilateral in both groups. Conclusions: The more widespread structural voxel-based morphometry abnormalities and worse IQ performance identified in the negative–family history (FH) group may result from a stronger environmental influence, including initial precipitating injuries. This is further support for the hypothesis that hippocampal sclerosis in mesial temporal lobe epilepsy with positive FH is determined by a stronger genetic predisposition with less influence of environmental factors compared with patients in the negative-FH group.

1 October 2016 in Anais Brasileiros de Dermatologia
Verified
Journal Article
Open access
PDF file
APAmanda Regio Pereira
Amanda Regio Pereira
LMLuis Henrique Barbizan de Moura
Luis Henrique Barbizan de Moura
JPJhonatan Rafael Siqueira Pinheiro
Jhonatan Rafael Siqueira Pinheiro
VPVictor Pavan Pasin
Victor Pavan Pasin
MEMilvia Maria Simões e Silva Enokihara
Milvia Maria Simões e Silva Enokihara
APAdriana Maria Porro
Adriana Maria Porro
Linear IgA dermatosis is a rare subepidermal autoimmune blistering disease characterized by linear deposition of IgA along the basement membrane zone. In the last three decades, many different drugs have been associated with the drug-induced form of the disease, especially vancomycin. We report a case of vancomycin-induced linear IgA disease mimicking toxic epidermal necrolysis. The aim of this work is to emphasize the need to include this differential diagnosis in cases of epidermal detachment and to review the literature on the subject and this specific clinical presentation.

15 February 2022 in Clinical and Experimental Dermatology
Verified
Journal Article
Open access
PDF file
APAmanda Regio Pereira
Amanda Regio Pereira
MCMarina Corral‐Forteza
Marina Corral‐Forteza
HCHelena Collgros
Helena Collgros
MSMary‐Ann El Sharouni
Mary‐Ann El Sharouni
PFPeter M. Ferguson
Peter M. Ferguson
PGPascale Guitera
Pascale Guitera
Background If 70% of cutaneous melanomas develop de novo, small-diameter or tiny lesions are expected to represent the earliest manifestation of most melanomas. Objectives To describe the clinical, histopathological and dermoscopic features of tiny melanomas; and to investigate the impact of imaging tools, including total body photography (TBP) and sequential digital dermoscopy imaging (SDDI) in their detection. Methods Consecutive melanomas diagnosed over 2 years in a referral centre were retrospectively included. Diameter ≤5mm on dermoscopy defined tiny melanomas. Dermoscopic features and performance of four methods were evaluated. Results 86/312 (27.6%) of the included melanomas measured ≤5mm. They were invasive in 44.2%. Tiny melanomas were more frequently excised for being new and/or changing compared to non-tiny melanomas (77.9% vs. 50.9%; P<.0001). Half of the tiny melanomas would have been missed by the dermoscopic 7-point checklist (48.2%) or the 3-point checklist (49.4%). Menzies’ method and the revised pattern analysis correctly identified respectively 65.9% and 63.5% of the tiny melanomas. The most frequent positive features for tiny melanomas were asymmetry in structure or colour (77.6%), brown dots (65.9%), irregular dots and globules (76.5%) and atypical pigment network (44.7%). Dermoscopic features predictive of invasion in tiny melanomas were (OR, 95%CI) atypical vascular pattern (26.5, 1.5-475.5, P=.002), shiny white lines (12.4, 0.7-237.8, P=0.04) and grey/blue structures (3.7, 1.3-10.5, P=0.01). Conclusions Tiny melanomas are frequently invasive and represent a clinical, dermoscopic and histopathological challenge. Dermoscopy alone has suboptimal diagnostic accuracy. Early diagnosis relies on the detection of new or changing lesions aided by TBP and SDDI.

1 January 2011 in Frontiers in Neurology
Verified
Journal Article
Open access
PDF file
LCLivia Conz
Livia Conz
MMMarcia Elisabete Morita
Marcia Elisabete Morita
ACAna Carolina Coan
Ana Carolina Coan
EKEliane Kobayashi
Eliane Kobayashi
UCUniversity lin Campinas
University lin Campinas
FCFernando Cendes
Fernando Cendes
Introduction: Studies have shown progressive cerebral damage in patients with refractory mesial temporal lobe epilepsy (MTLE). However, this has not been demonstrated in benign forms of MTLE such as familial mesial temporal lobe epilepsy (FMTLE). Purpose: To evaluate progression of hippocampal atrophy (HA) in patients with sporadic mesial temporal lobe epilepsy (SMTLE) and FMTLE by longitudinal Magnetic resonance images (MRIs) acquired with at least 7 months of interval. Method: We included 35 patients with FMTLE (25 classified as benign and 10 refractory) and 33 with SMTLE (4 benign and 29 refractory). All MRIs were analyzed by an investigator blind for clinical data. Hippocampal analyses were performed manually in coronal 3 mm thick T1 inversion recovery, using the software Scion Image®. Volumes were compared to those from a control group, and HA was determined for volumes below two standard deviations from the mean of controls. Results: The mean interval between the first (MRI1) and second MRI (MRI2) was 90 months for FMTLE and 45 months for SMTLE group. FMTLE group: volumetry demonstrated HA in 20 patients in MRI1 and in 23 patients in MRI2. There was significant progression of HA in FMTLE patients between MRIs in both benign and refractory FMTLE patients (benign FMTLE: right hippocampus, p = 0.001 and left hippocampus, p < 0.001; refractory FMTLE: right hippocampus, p = 0.022 and left hippocampus, p < 0.010). SMTLE group: volumetry demonstrated HA in 27 patients in MRI1 and in 29 patients in MRI2. In the group analysis, there was a significant reduction of the right (p < 0.0001) and left (p < 0.0001) hippocampal volumes during the follow-up period. Although the mean time between the MRIs in the FMTLE group was twice the time of the SMTLE group, the progression of volume loss was similar in both groups, indicating a slower progression in the FMTLE patients. Conclusion: FMTLE patients have progressive hippocampal volume reduction independently of seizure frequency although the progression of HA seems to be slower than in SMTLE.